1 Min Read
Sept 19 (Reuters) -
* AgeneBio receives NIH grant to initiate phase 3 HOPE4MCI trial to treat MCI due to alzheimer’s disease Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.